Want to join the conversation?
$PAYX said payroll revenue for 1Q17 & 2Q17 is expected to be at or above the full year guidance. For 3Q17, the company expects to be below the full year range and in 4Q17, payroll revenue is expected to be between 3-4%. HRS is expected to be within the full-year guidance range, with the exception of 3Q17, which will fall below the full year range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?